Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Gregory T. Went currently holds 232,541 shares of Adamas Pharmaceuticals Inc (ADMS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gregory T. Went has been a net seller of ADMS stock. They have purchased $50.0K and sold $1.0M worth of shares.
Gregory T. Went's most recent insider trade was on Apr 8, 2019, when they sold 56,250 shares at $0.00 per share.
Gregory T. Went serves as Executive at Adamas Pharmaceuticals Inc (ADMS). They have executed 54 insider transactions totaling $1.1M over their tenure at the company.
Gregory T. Went holds the position of Executive at Adamas Pharmaceuticals Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Gregory T. Went has shown a selling trading pattern, with $50.0K in total purchases and $1.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Gregory T. Went was on Mar 4, 2016, when they purchased $392.7K worth of ADMS shares. This transaction involved 28,750 shares at $13.66 per share.
Gregory T. Went currently owns 232,541 shares of Adamas Pharmaceuticals Inc (ADMS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Gregory T. Went's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Gregory T. Went has 54 Form 4 filings on record as an insider at Adamas Pharmaceuticals Inc.
Set alerts for Gregory T. Went and 40,000+ other insiders.